Pharmaceutical products

Tender description

Invitation to offer for NHS National Generic Pharmaceuticals — Wave 11. Offer reference number: CM/PHG/17/5530. Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 26 months. Potential periods of call-offs under the framework agreement: Hospital Only Products — Central and South West (CESW) 1.7.2018 to 31.7.2019 (13 months); North West and Eastern and North London (NWLN) 1.7.2018 to 31.7.2019 (13 months) and South East and South London and North East and Yorkshire (LSNE) 1.7.2018 to 31.7.2019 (13 months). Oral Products — All Regions 1.7.2018 to 28.2.2019 (8 months). NHS National Generic Pharmaceuticals — Wave 11. Offer reference number: CM/PHG/17/5530. Period of Framework Agreement: Dates detailed below with options to extend up to a maximum period of 26 months. Potential periods of call-offs under the framework agreement: Oral Products: All Regions 1.7.2018 to 28.2.2019 (8 months). NHS National Generic Pharmaceuticals — Wave 11. Offer Reference Number: CM/PHG/17/5530. Period of framework agreement: dates detailed below with options to extend to a maximum period of 26 months. Potential period of call-off under the framework agreement: Hospital Only Products: CESW 1.7.2018 to 31.7.2019 (13 months). NHS National Generic Pharmaceuticals — Wave 11. Offer Reference Number: CM/PHG/17/5530. Period of framework agreement: dates detailed below with options to extend to a maximum period of 26 months. Potential period of call-off under the framework agreement: Hospital Only Products: NWLN 1.7.2018 to 31.7.2019 (13 months). NHS National Generic Pharmaceuticals — Wave 11. Offer Reference Number: CM/PHG/17/5530. Period of framework agreement: dates detailed below with options to extend to a maximum period of 26 months. Potential period of call-off under the framework agreement: Hospital Only Products: LSNE 1.7.2018 to 31.7.2019 (13 months).